Company Fact Sheet
View Company
Fact Sheet [PDF 917KB]
Note: You'll need Adobe Acrobat® Reader to view and print
PDF files.
Get Adobe Acrobat® Reader. Follow the instructions provided.
Select a link below to jump down the page:
Company Overview
St. Jude Medical develops medical technology and services that focus on putting more control
into the hands of those who treat cardiac, neurological and chronic pain patients worldwide.
The company is dedicated to advancing the practice of medicine by reducing risk wherever
possible and contributing to successful outcomes for every patient. Headquartered in St. Paul, Minn.,
St. Jude Medical employs more than 14,000 people worldwide and has four major focus areas that include:
cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation.
The St. Jude Medical product portfolio includes implantable cardioverter defibrillators (ICDs),
cardiac resynchronization therapy (CRT) devices, pacemakers, electrophysiology catheters,
mapping and visualization systems, vascular closure devices, heart valve replacement and repair
products, and neurostimulation devices.
Company Facts
Global Headquarters: St. Paul, Minnesota
Website: www.sjm.com
Stock Exchange: New York Stock Exchange (NYSE) under "STJ" symbol
Founded: 1976 in St. Paul, Minnesota
2008 Net Sales: $4.363 billion
Global Reach: St. Jude Medical has operations and manufacturing facilities
worldwide, with products sold in more than 100 countries.
Employees: More than 14,000 employees worldwide.
Highlights
-
St. Jude Medical targets a minimum of 15 percent compounded annual growth in Earnings
Per Share through sustained double digit sales growth, improving margins to best
competitive benchmarks and the use of strong cash flow to repurchase stock and fund
disciplined acquisitions.
-
St. Jude Medical was one of only three large-cap health care companies to grow both
its top and bottom line at greater than 15 percent in 2008.
-
Five-year compounded annual growth rate was 17.4 percent from 2004 through 2008.
Growth at St. Jude Medical
St. Jude Medical is committed to continuous innovation and growth in its people, products and
programs. This growth will include investments in infrastructure, in the skills and development
of employees, and in the depth and breadth of the company's product portfolio. Examples of
recent significance for St. Jude Medical include:
-
Atrial fibrillation: St. Jude Medical is a pioneer in the atrial
fibrillation (AF) market. The Company has one of the broadest and deepest programs
in one of the best growth opportunities in medical devices. Technology such as the
EnSite Velocity™ cardiac mapping system, which creates detailed images of the heart
to help physicians diagnose and treat cardiac arrhythmias, demonstrates St. Jude
Medical's leadership in this area.
-
Connectivity: St. Jude Medical is focused on providing physicians
with timely, actionable data about patients' conditions and device statuses. With
the recent launch of the Accent RF pacemaker and Anthem RF CRT-P (cardiac
resynchronization therapy pacemaker), St. Jude Medical now offers integrated wireless
systems from implant through follow-up for both high and low voltage devices. The company's
Merlin.net patient care network (PCN) also allows physicians to compile a more complete
patient record, by easily transferring cardiac device data into electronic health records
(EHRs).
-
Neuromodulation: With the 2008 launch of the Eon® Mini
neurostimulator, the world's smallest and longest lasting rechargeable spinal cord
stimulator, St. Jude Medical has seen significant growth in its Neuromodulation
business. St. Jude Medical also received European approval in 2008 for the Libra™
Deep Brain Stimulation System for the treatment of Parkinson's disease, and completed
enrollment in its U.S. pivotal trial for Parkinson's disease this year.
Performance and Progress
Revenue (in millions)
Research & Development (in millions)
Reported Earnings Per Share
2008 Product Revenue Mix
2008 Sales By Geography
|
